Oral administration of Lactobacillus rhamnosus CCFM0528 improves glucose tolerance and cytokine secretion in high-fat-fed, streptozotocin-induced type 2 diabetic mice

Journal of Functional Foods

Volumn 10, Issue , 2014, Pages 318-326

  Chen, Pei ^a,b   Zhang, Qiuxiang ^a   Dang, Hui ^a,c   Liu, Xiaoming ^a   Tian, Fengwei ^a   Zhao, Jianxin ^a   Chen, Yongquan ^a,d   Zhang, Hao ^a   Chen, Wei ^a,d  

^a JIANGNAN UNIVERSITY   (China)

^b SHAANXI UNIVERSITY OF TECHNOLOGY   (China)

^c SHAANXI NORMAL UNIVERSITY   (China)

^d The Synergistic Innovation Center for Food Safety and Nutrition   (China)

Author keywords

Blood glucose; Glucose tolerance; Lactobacillus rhamnosus CCFM0528; Type 2 diabetic

Indexed keywords

LACTOBACILLUS RHAMNOSUS; MUS;

EID: 84920059044     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2014.06.014     Document Type: Article

References (41)

1. Ali A.A., Velasquez M.T., Hansen C.T., Mohamed A.I., Bhathena S.J. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. The Journal of Nutritional Biochemistry 2004, 15:583-590.
2. Apostolidis E., Li L., Lee C., Seeram N.P. In vitro evaluation of phenolic-enriched maple syrup extracts for inhibition of carbohydrate hydrolyzing enzymes relevant to type 2 diabetes management. Journal of Functional Foods 2011, 100-106.
3. Calcinaro F., Dionisi S., Marinaro M., Candeloro P., Bonato V., Marzotti S., Corneli R., Ferretti E., Gulino A., Grasso F. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia 2005, 48:1565-1575.
4. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
5. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
6. Chen P., Zhang Q.X., Dang H., Liu X.M., Tian F.W., Zhao J.X., Chen Y.Q., Zhang H., Chen W. Screening for potential new probiotic based on probiotic properties and α-glucosidase inhibitory activity. Food Control 2014, 35:65-72.
7. Ewaschuk J., Endersby R., Thiel D., Diaz H., Backer J., Ma M., Churchill T., Madsen K. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology (Baltimore, Md.) 2007, 46:841-850.
8. Feingold K.R., Grunfeld C. Role of cytokines in inducing hyperlipidemia. Diabetes 1992, 41(Suppl. 2):97-101.
9. Fujiwara D., Inoue S., Wakabayashi H., Fujii T. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. International Archives of Allergy and Immunology 2004, 135:205-215.
10. Hannu K. Milk-derived bioactive peptides: From science to applications. Journal of Functional Foods 2009, 1:177-187.
11. Hilton E., Kolakowski P., Singer C., Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. Journal of Travel Medicine 1997, 4:41-43.
12. Hsieh F.C., Lee C.L., Chai C.Y., Chen W.T., Lu Y.C., Wu C.S. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutrition and Metabolism 2013, 10:35.
13. Huang H.Y., Korivi M., Tsai C.H., Yang J.H., Tsai Y.C. Supplementation of Lactobacillus plantarum K68 and fruit-vegetable ferment along with high fat-fructose diet attenuates metabolic syndrome in rats with insulin resistance. Evidence-Based Complementary and Alternative Medicine 2013, 2013.
14. Jain S., Saraf S. Type 2 diabetes mellitus - its global prevalence and therapeutic strategies. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2010, 4:48-56.
15. Khanal R.C., Howard L.R., Wilkes S.E., Rogers T.J., Prior R.L. Cranberry pomace partially ameliorates metabolic factors associated with high fructose feeding in growing Sprague-Dawley rats. Journal of Functional Foods 2010, 4:284-291.
16. Ko K.S., Lee M., Koh J.J., Kim S.W. Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice. Molecular Therapy: The Journal of the American Society of Gene Therapy 2001, 4:313-316.
17. Laitinen K., Poussa T., Isolauri E. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: A randomised controlled trial. The British Journal of Nutrition 2009, 101:1679-1687.
18. Lutgendorff F., Trulsson L.M., van Minnen L.P., Rijkers G.T., Timmerman H.M., Franzen L.E., Gooszen H.G., Akkermans L.M.A., Soderholm J.D., Sandstrom P.A. Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 295:G1111-G1121.
19. Madsen K., Cornish A., Soper P., McKaigney C., Jijon H., Yachimec C., Doyle J., Jewell L., De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121:580-591.
20. Matsuzaki T., Nagata Y., Kado S., Uchida K., Kato I., Hashimoto S., Yokokura T. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 1997, 105:643-649.
21. Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocrine Journal 1997, 44:357-365.
22. Menassa R., Nguyen V., Jevnikar A., Brandle J. A self-contained system for the field production of plant recombinant interleukin-10. Molecular Breeding 2001, 8:177-185.
23. Monteagudo-Mera A., Rodríguez-Aparicio L., Rúa J., MartínezBlanco H., Navasa N., Garca-Armesto M.R., Ferrero M.A. In vitro evaluation of physiological probiotic properties of different lactic acid bacteria strains of dairy and human origin. Journal of Functional Foods 2012, 4:531-541.
24. Nuño K., Villarruel-López A., Puebla-Pérez A.M., Romero-Velarde E., Puebla-Mora A.G., Ascencio F. Effects of the marine microalgae Isochrysis galbana and Nannochloropsis oculata in diabetic rats. Journal of Functional Foods 2013, 5:106-115.
25. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA: The Journal of the American Medical Association 2001, 286:327-334.
26. Prangthip P., Surasiang R., Charoensiri R., Leardkamolkarn V., Komindr S., Yamborisut U., Vanavichit A., Kongkachuichai R. Amelioration of hyperglycemia, hyperlipidemia, oxidative stress and inflammation in steptozotocin-induced diabetic rats fed a high fat diet by riceberry supplement. Journal of Functional Foods 2013, 5(1):195-203.
27. Rabinovitch A., Suarez-Pinzon W.L. Cytokines and their roles in pancreatic islet β-cell destruction and insulin-dependent diabetes mellitus. Biochemical Pharmacology 1998, 55:1139-1149.
28. Rizzardini G., Eskesen D., Calder P.C., Capetti A., Jespersen L., Clerici M. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: A randomised, double-blind, placebo-controlled study. The British Journal of Nutrition 2012, 107:876-884.
29. Rotter V., Nagaev I., Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. The Journal of Biological Chemistry 2003, 278:45777-45784.
30. Schultz M., Veltkamp C., Dieleman L.A., Grenther W.B., Wyrick P.B., Tonkonogy S.L., Sartor R.B. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflammatory Bowel Diseases 2002, 8:71-80.
31. Srinivasan K., Ramarao P. Animal models in type 2 diabetes research: An overview. The Indian Journal of Medical Research 2007, 125:451-472.
32. Stumvoll M., Mitrakou A., Pimenta W., Jenssen T., Yki-Järvinen H., Van Haeften T., Renn W., Gerich J. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000, 23:295-301.
33. Tabuchi M., Ozaki M., Tamura A., Yamada N., Ishida T., Hosoda M., Hosono A. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Bioscience, Biotechnology, and Biochemistry 2003, 67:1421-1424.
34. Tucker A., Vandermey J., Robinson L., Graham T., Bakovic M., Duncan A. Effects of breads of varying carbohydrate quality on postprandial glycaemic, incretin and lipidaemic response after first and second meals in adults with diet-controlled type 2 diabetes. Journal of Functional Foods 2013, 6:116-125.
35. Ulisse S., Gionchetti P., D'Alò S., Russo F.P., Pesce I., Ricci G., Rizzello F., Helwig U., Cifone M.G., Campieri M. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: Effects of probiotic treatment. The American Journal of Gastroenterology 2001, 96:2691-2699.
36. van Exel E., Gussekloo J., de Craen A.J.M., Frölich M., Bootsma-van der Wiel A., Westendorp R.G.J. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes - the Leiden 85-plus study. Diabetes 2002, 51:1088-1092.
37. Vaarala O. Immunological effects of probiotics with special reference to lactobacilli. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 2003, 33:1634-1640.
38. Yadav H., Jain S., Sinha P. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition (Burbank, Los Angeles County, Calif.) 2007, 23:62-68.
39. Yun S.I., Park H.O., Kang J.H. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. Journal of Applied Microbiology 2009, 107:1681-1686.
40. Zhang Y., Wang L.F., Zhang J.C., Li Y.X., He Q.W., Li H., Guo X., Guo J.L., Zhang H.P. Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. European Journal of Nutrition 2013, 10.1007/s00394-013-0519-5.
41. Zimmet P., Alberti K.G.M.M., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.